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Background
In animals and human subjects, an increase in back-
ground signal intensity observed on late gadolinium
enhanced (LGE-SI) images is associated with a decrement
in left ventricular ejection fraction (LVEF) during receipt
of anthracycline chemotherapy. Moran’s I statistic is a
measurement of spatial dispersion of hyperenhanced vox-
els relative to the mean myocardial LGE-SI, ranging from
highly clustered (I=+1) to highly diffuse (I=-1) (Figure 1).
We hypothesize that a change in the distribution of
hyperenhanced voxels (due to the development of high
signal “micro clusters”) is associated with a decrement in
LVEF after cardiotoxic chemotherapy.
Methods
We performed a prospective, extramurally-funded longi-
tudinal cohort study of 51 participants (43 women, 8
men; aged 52±2 years) scheduled to receive 3 to 4
months of potentially cardiotoxic chemotherapy (anthra-
cycline or trastuzumab) for treatment of breast cancer or
hematologic malignancy. Before and then 3 and 6 months
after chemotherapy initiation, participants underwent
cardiovascular magnetic resonance (CMR) assessments
of LVEF, LGE-SI, and Moran’s I statistic determined by
personnel blinded to participant identifiers and all other
aspects of the analyses. Results were analyzed using
paired Student’s t-tests to test for a difference between
baseline and subsequent examinations, and one-way
ANOVA to test for trending change. All values are
reported as mean ± standard deviation with p-values<0.05
considered statistically signficant.
Results
37 participants were treated for breast cancer and 14 for
hematologic malignancy. A declining LVEF from base-
line (58±6%) was observed three months (54±7%) and
six months (53±7%) after beginning chemotherapy
(p<0.0001 for trend, Figure 2A). Mean LGE-SI, reflecting
a change in myocardial T1 relaxation, increased from
14.0±5.5 at baseline to 16.1±7.6 three months after
starting chemotherapy (p=0.03, Figure 2B) and remained
elevated at 6 months (15.7±6.8, p=0.07 from baseline).
At baseline and 3 months, the patterns of LGE-SI
hyperenhancement (Moran’s I statistic) showed random
distribution (-0.02±0.02 and -0.02±0.01, respectively;
p=0.91). Six months after chemotherapy initiation, myo-
cardial LGE-SI hyperenhanced voxels became more dif-
fusely distributed as shown in Figure 2C (I=-0.12±0.14,
p<0.001).
Conclusions
We observed that, six months after receipt of che-
motherapy, increased late gadolinium enhancement sig-
nal intensity (LGE-SI) occurs in a diffusely distributed
pattern within the myocardium concurrent with a
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declining LVEF. Moran’s I statistic is a novel method to
discriminate processes related to a diffuse increase in
myocardial T1 (fibrosis, edema) from those related to a
clustered increase in myocardial T1 (infarct); further
investigations are warranted to study the utility of Mor-
an’s I statistic with T1 and T2 mapping.
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Figure 1 Illustration of the spatial autocorrelation statistic, Moran’s I,
which describes the distribution of values in a volume in relation to
their difference from the mean value and proximity to other voxels of
similar intensity value. Moran’s I ranges from I=-1 (diffuse distribution)
to I=+1 (clustered distribution) and I=0 represents random distribution
in the volume of values different from the mean value. Each illustration
in the image contains the same number of white dots (or mean value)
but different patterns of distribution.
Figure 2 Longitudinal measurements of left ventricular ejection
fraction (LVEF, Panel A), late gadolinium enhancement signal intensity
(LGE-SI, Panel B), and LGE-SI pattern (Moran’s I, Panel C) measured with
1.5T cardiovascular magnetic resonance prior to chemotherapy
administration (month 0) and again 3 and 6 months after
administration of cardiotoxic chemotherapy. Mean values ± standard
deviation shown in each panel. Significant differences from baseline by
paired t-tests with p-values<0.05 indicated by (*); p-value listed in each
panel is for analysis of trend using one-way ANOVA.
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